The objective of this study was to identify risk factors associated with flare during pregnancy in women with systemic lupus erythematosus (SLE). We performed a retrospective analysis of pregnant women with SLE in a referral hospital. Flare was considered according to predetermined definitions. We analyzed 15 clinical, biochemical and immunological variables with a potential predictive value for relapse during pregnancy. We included 124 lupus pregnancies in 120 women. The relapse rate during pregnancy was 37.9% (47 episodes). The most common manifestations of flare were renal, joint, cutaneous and hematological. Patients with flare during pregnancy developed a higher frequency of preeclampsia and preterm delivery. In multivariate analysis, primigravida was a risk factor associated with any type of flare during pregnancy (OR 2.3, 95% CI 0.99–5.52, p = 0.05); on the other hand, primigravida (OR 3.6, 95% CI 1.19–11.3, p = 0.02), activity prior to pregnancy (OR 3.7, 95% CI 0.97–14.1, p = 0.05), and previous renal disease (OR 5.8, 95% CI 1.95–17.6, p = 0.001) were the principal risk factors associated with renal flare. The first pregnancy in women with SLE is associated with any type of flare. Disease activity is associated with preeclampsia and preterm delivery. Close monitoring is mandatory to identify relapses and timely treatment.
ClowseME. Lupus activity in pregnancy. Rheum Dis Clin North Am2007; 33: 237–252.
2.
Cortés-HernándezJOrdi-RosJParedesFCasellasMCastilloFVilardell-TarresM. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: A prospective study of 103 pregnancies. Rheumatology (Oxford)2002; 41: 643–650.
3.
DoriaAGhiradelloAIaccarinoL. Pregnancy, cytokines, and disease activity in systemic lupus erythematosus. Arthritis Rheum2004; 51: 989–995.
4.
ClowseMEMagderLSWitterFPetriM. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum2005; 52: 514–521.
5.
ClowseMEMagderLWitterFPetriM. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum2006; 54: 3640–3647.
6.
GladmanDDTandonAIbañezDUrowitzMB. The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications. J Rheumatol2010; 37: 754–758.
7.
SaavedraMACruz-ReyesCVera-LastraO. Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancy. Clin Rheumatol2012; 31: 813–819.
8.
ImbasciatiETincaniAGregoriniG. Pregnancy in women with pre-existing lupus nephritis: Predictors of fetal and maternal outcome. Nephrol Dial Transplant2009; 24: 519–525.
9.
ClowseMEMagderLSWitterFPetriM. Early risk factors for pregnancy loss in lupus. Obstet Gynecol2006; 107: 293–299.
10.
TanEMCohenASFriesJF. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1982; 25: 1271–1277.
11.
HochbergMC. Updating of American College of Rheumatology revised criteria for the classification criteria of systemic lupus erythematosus. Arthritis Rheum1997; 40: 1725–1725.
12.
MiyakisSLockshinMDAtsumiT. International consensus statement on an update of the classification criteria for definitive antiphospholipid syndrome (APS). J Thromb Haemost2006; 4: 295–306.
13.
RupertoNHanrahanLMAlarcónGS. International consensus for a definition of disease flare in lupus. Lupus2011; 20: 453–462.
14.
UzanJCarbonnelMPiconneOAsmarRAyoubiJM. Pre-eclampsia: Pathophysiology, diagnosis and management. Vasc Health Risk Manag2011; 7: 467–474.
15.
ShahP. Parity and low birth weight and preterm birth: A systematic review and meta-analyses. Acta Obstet Gynecol2010; 89: 862–875.
16.
Laresgoiti-ServitjeEGomez-LopezN. The pathophysiology of preeclampsia involves altered levels of angiogenic factors promoted by hypoxia and autoantibody-mediated mechanisms. Biol Reprod2012; 87: 361–367.
17.
JaraLJMedinaGNavarroCSaavedraMABlanco-FavelaFEspinozaLRPregnancy, hormones, and autoimmune diseases. In: WalkerSEJaraLJ (eds). Handbook of systemic autoimmune diseases, Vol. 9. Endocrine manifestations of systemic autoimmune diseases, Oxford: Elsevier Science Ltd, 2008, pp. 185–197.
18.
UrowitzMBGladmanDDFarewellVTStewartJMcDonaldJ. Lupus and pregnancy studies. Arthritis Rheum1993; 36: 1392–1397.
19.
HuongDLWechslerBVauthier-BrouzesDBeaufilsHLefebvreGPietteJC. Pregnancy in past or present lupus nephritis: A study of 32 pregnancies from a single center. Ann Rheum Dis2001; 60: 599–604.
20.
MoroniGQuagliniSBanfiG. Pregnancy in lupus nephritis. Am J Kidney Dis2002; 40: 713–720.
21.
WagnerSJCraiciIReedD. Maternal and foetal outcomes in pregnant patients with active lupus nephritis. Lupus2009; 18: 342–347.
22.
KarimMYD’CruzDP. Practical management of lupus nephritis in pregnancy and the puerperium. Expert Rev Clin Pharmacol2010; 3: 777–784.
23.
GladmanDDTandonAIbañezDUrowitzMB. The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications. J Rheumatol2010; 37: 754–758.
24.
CutoloMCapellinoSSulliA. Estrogens and autoimmune diseases. Ann N Y Acad Sci2006; 1089: 538–547.
25.
DoriaAIaccarinoLArientiS. Th2 immune deviation induced by pregnancy: The two faces of autoimmune rheumatic diseases. Reprod Toxicol2006; 22: 234–241.
26.
DoriaAGhirardelloAIaccarinoL. Pregnancy, cytokines and disease activity in systemic lupus erythematosus. Arthritis Rheum2004; 51: 989–995.
27.
JaraLJPacheco-ReyesHMedinaGUlisesACruz-CruzPSaavedraMA. Prolactin levels are associated with lupus activity, lupus anticoagulant, and poor outcome in pregnancy. Ann N Y Acad Sci2007; 1108: 218–226.
28.
VargheseSCrockerIBruceITowerC. Systemic lupus erythematosus, regulatory T cells and pregnancy. Expert Rev Clin Immunol2011; 7: 635–648.
29.
ØstensenMVilligerPMFörgerF. Interaction of pregnancy and autoimmune rheumatic disease. Autoimmun Rev2012; 11: A437–A446.
30.
TowerCCrockerIChiricoDBakerPBruceI. SLE and pregnancy: The potential role for regulatory T cells. Nat Rev Rheumatol2011; 7: 124–128.
31.
ClarkCASpitzerKANadlerJNLaskinCA. Preterm deliveries in women with systemic lupus erythematosus. J Rheumatol2003; 30: 2127–2132.
32.
ChakravartyEFColonILangenES. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol2005; 192: 1897–1904.
33.
ClowseMEWallaceDJWeismanMJamesACriscione-SchreiberLGPisetskyDA. Predictors of preterm birth in patients with mild systemic lupus erythematosus. Ann Rheum Dis2013; 72: 1536–1539.
34.
ClowseMEMagderLSPetriM. The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus. J Rheumatol2011; 38: 1012–1016.
35.
YuenSYKrizovaAOuimetJMPopeJE. Pregnancy outcome in systemic lupus erythematosus (SLE) is improving: Results from a case control study and literature review. Open Rheumatol J2008; 2: 89–98.
36.
BuyonJPKalunianKCRamsey-GoldmanR. Assessing disease activity in SLE patients during pregnancy. Lupus1999; 8: 677–684.
37.
Ruiz-IrastorzaGKhamashtaMAGordonC. Measuring systemic lupus erythematosus activity during pregnancy: Validation of the lupus activity index in pregnancy scale. Arthritis Rheum2004; 51: 78–82.
38.
LateefAPetriM. Management of pregnancy in systemic lupus erythematosus. Nat Rev Rheumatol2012; 8: 710–718.
